About Us About Us

Progenics Pharmaceuticals
Comprehensive Compliance Program Description

I. Introduction

Progenics Pharmaceuticals, Inc. (Progenics) is committed to conducting its business in compliance with all applicable laws, rules, and regulations and the highest standards of ethical conduct. To this end, we have established and will maintain a Comprehensive Compliance Program (“Compliance Program”) in accordance with the OIG Compliance Program Guidance for Pharmaceutical Manufacturers (the “OIG Guidance”) published by the Office of Inspector General, U.S. Department of Health and Human Services. Our Compliance Program is a key component of our commitment to adhering to the highest standards of corporate responsibility and fostering a culture of compliance that places a premium on doing business with integrity.

The purpose of our Compliance Program is to (1) prevent, detect, and remediate violations of laws, rules, regulations, as well as Progenics policies and procedures and (2) promote a culture of the highest ethics within the organization. It is Progenics’ expectation that employees will comply with our Code of Business Ethics and Conduct and the policies and procedures established in support of such Code. As the OIG Guidance recognizes, however, the implementation of a Compliance Program cannot guarantee the elimination of improper employee conduct.

Progenics has described below the fundamental elements of our Compliance Program. As recognized in the OIG Guidance, we have tailored our Compliance Program to fit the unique environment of our company. Moreover, our Compliance Program is dynamic and we regularly review and enhance our Compliance Program to meet our evolving compliance needs.
You may obtain a copy of this Compliance Program description by calling 844-293-3721.

II. Overview of Compliance Program

Compliance Governance

Compliance Officer. Progenics has appointed a Compliance Officer who is charged with developing, implementing, and monitoring the Compliance Program. We will ensure that the Compliance Officer has the ability to exercise independent judgment and effectuate change within the organization as needed. The Compliance Officer reports to the President and Chief Executive officer of Progenics, is the chair of the Progenics’ Compliance Committee, and has direct access to the Progenics Board of Directors.

Compliance Committee. Progenics has established a Compliance Committee made up of Progenics senior management. The role of the Compliance Committee is to advise and assist the Compliance Officer in the development, implementation, and ongoing oversight of the Compliance Program. The Compliance Committee meets on a regular basis to identify and manage areas of risk and areas of critical focus for the Compliance Program. Progenics also has established a Board-level Compliance Committee, the purpose of which, as set forth in the Compliance Committee Charter (https://ir.progenics.com/static-files/2892bca0-bed4-4ae4-80a6-e6adad18f7c6) , is to oversee the Company’s compliance with legal and regulatory requirements and internal business ethics policies.

Written Policies and Procedures

Progenics has established policies and procedures, including our Code of Business Ethics and Conduct, which articulate our fundamental principles and values and provide a framework for ethical conduct within our organization. The Code of Business Ethics and Conduct establishes our expectation that management, employees, and agents of Progenics act in accordance with all applicable laws, rules, regulations, and Progenics policies and procedures, as well as the highest standards of ethics.

Progenics has established an annual spending limit for certain promotional activities directed toward healthcare professionals who prescribe or may influence prescribing in California. At the present time our annual spending limit is $1500. Examples of items that fall within this spending limit are occasional modest meals in connection with informational presentations and educational items. This annual spending limit does not include payments to healthcare professionals for bona fide consulting or other services.

It is Progenics’s policy to not provide any item of value to any healthcare professional with the intent of influencing that healthcare professional’s prescribing habits.

Education and Training

A crucial element of our Compliance Program is the education and training of our employees on their legal and ethical obligations under applicable laws, rules, regulations, and company policies and procedures. Progenics regularly communicates our policies and procedures to ensure a thorough understanding of the company’s expectations and regularly reviews and updates these training programs.

Lines of Communication

Progenics actively fosters dialogue between management and employees. Our goal is that all employees should know to whom to turn when seeking answers to questions or reporting possible violations of company policies or procedures, and understand that they can make such reports without fear of retaliation. To that end, we have adopted an open-door policy, as well as confidentiality and non-retaliation policies. We have a confidential, toll-free compliance hotline to which employees and persons outside of Progenics may anonymously report any concerns or suspected violations of applicable laws, rules, regulations, or Progenics policies or procedures.

Auditing and Monitoring

Progenics’ Compliance Program includes monitoring and auditing to evaluate adherence to Progenics’s policies and procedures. We note that, in accordance with the OIG Guidance, the nature, extent, and frequency of our compliance monitoring and auditing may vary according to new regulatory requirements, changes in business practices, and other considerations.

Responding to Potential Violations

When Progenics becomes aware of potential violations of applicable laws, rules, or regulations or company policies or procedures, the company will promptly investigate such matters and make a determination as to whether the facts substantiate the existence of a violation. Progenics will document the conduct of such investigations.

Disciplinary and Corrective Action

While each substantiated violation will be considered on a case-by-case basis, where appropriate we will utilize disciplinary action consistent with company policy to address violative conduct and to deter future violations. We will also work to determine the root cause of the violation and assess whether the violation is due to gaps in company policies or procedures and take appropriate corrective action designed to prevent future violations.

III. Declaration of Compliance

Progenics Pharmaceuticals, Inc. hereby declares that, to the best of our knowledge, information, and belief, and based upon our good-faith understanding of the statutory requirements, we have, as of July 1, 2018, established a Comprehensive Compliance Program that is in material compliance with the requirements of California Health and Safety Code §§ 119400-119402. While Progenics’ Comprehensive Compliance Program cannot completely eliminate the possibility that an individual employee will engage in improper conduct, our program is reasonably designed to prevent and detect violations of applicable laws, rules, and regulations, as well as our own internal policies and procedures.